“Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma” (2019) Innovative Journal of Medical and Health Sciences, 9(1), pp. 247–251. doi:10.15520/ijmhs.v9i1.2431.